Overseas-invested hospitals to push China's healthcare reforms

Want China Times, Xinhua 2014-09-01

People line up at a children's hospital in Shanxi. (File photo/Xinhua)

The Chinese government's green-lighting of wholly overseas-funded private hospitals this week will have brought a smile to the faces of people like Benny Li.

Li, a senior manager of a US-based internet company in Beijing, did not consider private treatment until he became aware of the huge discrepancy in service standards between overseas-invested hospitals and their local counterparts in 2012.

One day that year, Li rushed to a local hospital after injuring his head in an accident. Pressing the bleeding wound with a hand, he waited for 40 minutes, along with several other patients suffering burns or cuts, before having three stitches put in his head.

"An old nurse kept telling us, 'No hurry, you won't die anyway,'" he recalled. Frustrated, days later Li for the first time went to a US-invested hospital in the Chinese capital, for a check up on his head wound.

"The doctor was amazed. He said he had never seen such sparse stitches, and carefully redid the job," Li said. Since then, the 34-year-old has been a die-hard fan of the hospital.

"In this hospital, you don't need to line up for hours to have a five-minute talk with a weary doctor, or speculate on how many kickbacks he gets from the medicine he prescribes," he said.

On Wednesday, the Chinese government said it will allow private hospitals solely owned by overseas investors to open in Beijing, Tianjin, Shanghai, Jiangsu, Fujian, Guangdong and Hainan, all in the country's developed eastern and southern regions.

Authorities and analysts believe that the opening up of China's healthcare sector will boost the development of more high-end medical services and inspire public hospitals to up their game.

In late July, German healthcare provider Artemed Group signed an agreement to establish a hospital in the Shanghai Pilot Free Trade Zone (FTZ). It will be the first wholly overseas-funded medical institution in the FTZ, launched last September as part of China's opening-up drive.

Currently, overseas-funded hospitals operating in the country are mostly joint ventures with Chinese investors. Only two private hospitals, one in Shanghai and the other in Shenzhen, Guangdong province, are solely funded by Taiwan and Hong Kong investors respectively.

Overseas-invested hospitals generally provide better service and ease the shortage of high-end medical institutions in Beijing, said Zhong Dongbo, deputy head of the Beijing Health and Family Planning Commission.

What China's medical market needs is advanced management expertise, service, equipment and technology, said Pan Zhongying, president of Beijing United Family Hospital, which was founded in 1997 and is now China's largest overseas-invested healthcare provider.

Wholly overseas-funded hospitals play a supplementary role in China's healthcare sector, according to Zhuang Yiqiang, deputy secretary general of the Chinese Hospital Association.

Chen Yude, professor with Peking University's Health Science Center, expects the competition following the entry of overseas-owned hospitals to push forward the reform of China's public healthcare institutions.

Chen said overseas-invested hospitals will deal a blow to their local counterparts since they will scramble for talented medical staff as well as patients.

Overseas-invested hospitals mainly serve foreigners working or living in China and high-income Chinese citizens, while China's healthcare sector is expected to be worth 8 trillion yuan (US$1.3 trillion) by 2020.

According to the National Health and Family Planning Commission, non-public healthcare institutions account for 47% of the country's total, however, the number of beds they provide takes up only 11%. This is expected to reach 20% by 2015.

Public hospitals provide 90% of China's medical services and most Chinese patients like to go to large public hospitals in big cities for medical treatment, leading to overcrowding.

In terms of funding and service standards, wholly overseas-funded hospitals are superior to local private ones, said Cai Jiangnan, a healthcare researcher with the China Europe International Business School in Shanghai.

"[The new ruling] is a good thing for ordinary people because overseas-funded hospitals will be a competitor for Chinese private and public hospitals," he said.

But others stated that there are challenges that new private hospitals will face too, adding that there needs to be development in related fields if private healthcare is to really take off.

Ordinary people have to first face the relatively high prices in overseas-funded hospitals. Currently, such costs cannot be covered by their basic medical insurance.

Taiwanese-owned Shanghai Landseed International Hospital, founded in 2002, has the capacity to receive 800 to 1,000 patients for clinical services each day, but the number they actually receive is only 300 to 400.

"The service is good there, but the costs cannot be covered by our medical insurance. The hospital is for the rich," said a Shanghai resident who declined to be named.

Given the market-oriented pricing of overseas-funded hospitals, China should encourage the development of the commercial health insurance industry to relieve the pressure on individuals who only have basic medical insurance, said Liang Hong, vice president of the China Health Insurance Research Association.

Staff recruitment also poses a challenge for overseas-funded hospitals. Under Chinese law, overseas doctors practicing clinical and treatment services in China must renew their registration every year.

Since 2009, China has loosened restrictions on doctors in terms of their being allowed to practice in multiple medical institutions, but the flow of medical staff in public hospitals still faces some barriers, according to experts.

"We must wait and see how the prospects for overseas-funded hospitals develop. The key lies in the overall further opening up and reform of China's medical services market," said Zhu Hengpeng, a public policy expert at the Chinese Academy of Social Sciences.